ABVD (8 cycles) versus BEACOPP (4 escalated cycles ≥4 baseline): final results in stage III–IV low-risk Hodgkin lymphoma (IPS 0–2) of the LYSA H34 randomized trial von Mounier, N., Brice, P., Bologna, S., Briere, J., Gaillard, I., Heczko, M., Gabarre, J., Casasnovas, O., Jaubert, J., Colin, P., Delmer, A., Devidas, A., Bachy, E., Nicolas-Virelizier, E., Aoudjhane, A., Humbrecht, C., Andre, M., Carde, P.

Volltext

Requirement for 3‐ketoacyl‐CoA thiolase‐2 in peroxisome development, fatty acid β‐oxidation and breakdown of triacylglycerol in lipid bodies of Arabidopsis seedlings von Germain, Véronique, Rylott, Elizabeth L., Larson, Tony R., Sherson, Sarah M., Bechtold, Nicole, Carde, Jean‐Pierre, Bryce, James H., Graham, Ian A., Smith, Steven M.

Volltext

OP32 Late effects in survivors of Hodgkin's lymphoma von Carde, P

Volltext

A ubiquitous plant housekeeping gene, PAP, encodes a major protein component of bell pepper chromoplasts von Pozueta-Romero, J, Rafia, F, Houlne, G, Cheniclet, C, Carde, J.P, Schantz, M.L, Schantz, R

Volltext

First-line escalated BEACOPP does not hinder stem cell collection and transplantation strategy in patients with relapsed/refractory Hodgkin’s lymphoma von Ghez, D, Fortpied, C, Mounier, N, Carde, P, Perrot, A, Khaled, H, Amorim, S, Ramadan, S, Bras, F L, Erlanson, M, Herbaux, C, Marolleau, J-P, Nicolas-Virelezier, E, Casasnovas, O, Stamatoullas-Bastard, A, Fermé, C

Volltext

Telomere shortening: a new prognostic factor for cardiovascular disease post-radiation exposure von M'kacher, R, Girinsky, T, Colicchio, B, Ricoul, M, Dieterlen, A, Jeandidier, E, Heidingsfelder, L, Cuceu, C, Shim, G, Frenzel, M, Lenain, A, Morat, L, Bourhis, J, Hempel, W M, Koscielny, S, Paul, J F, Carde, P, Sabatier, L

Volltext

Reply to C.F. Hess et al von Carde, Patrice P, Grynberg, Michael, Poirot, Catherine, Glimelius, Bengt, Mounier, Nicolas

Volltext

OC-0055: Telomere shortening in lymphocytes of Hodgkin lymphoma with coronary artery disease post treatment von M'kacher, R, Girinsky, T, Colicchio, B, Ricoul, M, Heidingsfelder, L, Bourhis, J, Koscielny, S, Paul, J.F, Carde, P, Sabatier, L

Volltext

JC human polyomavirus is associated to chromosomal instability in peripheral blood lymphocytes of Hodgkin’s lymphoma patients and poor clinical outcome von M’kacher, R., Andreoletti, L., Flamant, S., Milliat, F., Girinsky, T., Dossou, J., Violot, D., Assaf, E., Clausse, B., Koscielny, S., Bourhis, J., Bosq, J., Bernheim, A., Parmentier, C., Carde, P.

Volltext

PROGNOSTIC VALUE OF IMMUNOHISTOCHEMICAL MARKERS IN STAGE III/IV CLASSICAL HODGKIN LYMPHOMA TREATED FRONTLINE IN THE LYSA EORTC 20012 RANDOMIZED PROTOCOL von Canioni, D., Brice, P., Bologna, S., Voillat, L., Gabarre, J., Casasnovas, O., Devidas, A., Coiffier, B., Aoudjhane, A., Audouy, B., Andre, M., Fortpied, C., Carde, P., Mounier, N., Briere, J.

Volltext

Multicenter Phase Ib/II Trial of the Radiation Enhancer Motexafin Gadolinium in Patients With Brain Metastases von CARDE, Patrice, TIMMERMAN, Robert, MEHTA, Minesh P, KOPROWSKI, Christopher D, FORD, Judith, TISHLER, Roy B, MILES, Dale, MILLER, Richard A, RENSCHLER, Markus F

Volltext

LEFPS1, a Tomato Farnesyl Pyrophosphate Gene Highly Expressed during Early Fruit Development von Joel Gaffe, Jean-Philippe Bru, Mathilde Causse, Alain Vidal, Linda Stamitti-Bert, Carde, Jean-Pierre, Philippe Gallusci

Volltext

Standard Chemotherapy With or Without High-Dose Chemotherapy for Aggressive Non-Hodgkin's Lymphoma: Randomized Phase III EORTC Study von Kluin-Nelemans, Hanneke C., Zagonel, Vittorina, Anastasopoulou, Anastasia, Bron, Dominique, Roozendaal, Klaas J., Noordijk, Ed M., Musson, Helen, Teodorovic, Ivana, Maes, Brigitte, Carbone, Antonino, Carde, Patrice, Thomas, José

Volltext

The achievements of the EORTC Lymphoma Group von Raemaekers, J, Kluin-Nelemans, H, Teodorovic, I, Meerwaldt, C, Noordijk, E, Thomas, J, Glabbeke, M.van, Henry-Amar, M, Carde, P

Volltext

Early response to chemotherapy: a surrogate for final outcome of Hodgkin's disease patients that should influence initial treatment length and intensity? von Carde, P., Koscielny, S., Franklin, J., Axdorph, U., Raemaekers, J., Diehl, V., Aleman, B., Brosteanu, O., Hasenclever, D., Oberlin, O., Bonvin, N., Björkholm, M.

Volltext

The chemotherapy/radiation balance in advanced Hodgkin's lymphoma: overweight which side? von Carde, Patrice

Volltext

Multiple molecular mechanisms contribute to radiation sensitivity in mantle cell lymphoma von M'KACHER, R, BENNACEUR, A, STOPPA-LYONNET, D, RIBRAG, V, CARDE, P, PARMENTIER, C, BERNHEIM, A, TURHAN, A. G, FARACE, F, LAUGE, A, PLASSA, L. F, WITTMER, E, DOSSOU, J, VIOLOT, D, DEUTSCH, E, BOURHIS, J

Volltext

CLC-Nt1, a putative chloride channel protein of tobacco, co-localizes with mitochondrial membrane markers von Lurin, C, Güclü, J, Cheniclet, C, Carde, J P, Barbier-Brygoo, H, Maurel, C

Volltext

Baseline and treatment-induced chromosomal abnormalities in peripheral blood lymphocytes of Hodgkin's lymphoma patients von M'kacher, R, Girinsky, T, Koscielny, S, Dossou, J, Violot, D, Béron-Gaillard, N, Ribrag, V, Bourhis, J, Bernheim, A, Parmentier, C, Carde, P

Volltext

Clinical achievements of the EORTC Lymphoma Group and aspects of future group strategy von Meijnders, P, Carde, P, Girinsky, T, Kluin-Nelemans, J.C, Henry-Amar, M, Raemaekers, J.M.M, Karrasch, M, van der Maazen, R

Volltext